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Abstract The effect of mutation proline 17 on the multiple
conformations and catalytic function in chicken muscle adenylate
kinase (AK) has been studied. The substitution of proline 17 with
glycine or valine altered the distribution of multiple conforma-
tions. Compared with the wild-type enzyme, the P17G and P17V
mutants contained decreased fraction of minor conformer from
18% to 9% and 11%, respectively. Due to the mutation, the
enzyme showed lower secondary structural content, poorer
affinity to substrates or substrate analogues, and reduced
catalytic efficiency. The results revealed the significance of
proline 17 in the conformation and function of AK. ß 2001
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Proline is unique among the amino acids with its ¢ve-mem-
ber ring. Thus, proline residues play speci¢c structural roles:
as N-terminal caps to K-helices, as helix termination signals,
as corner residues in L-turn sequences. Moreover, cis and
trans conformations of Xaa^Pro bonds have comparable en-
ergies, leading to a 10^30% population of cis Xaa^Pro in the
unfolded assemble and an about 6% frequency of cis Xaa^Pro
bonds that are in native proteins [1,2]. As a result, some
proteins show structural heterogeneity in the native state
due to isomerization about a Xaa^Pro peptide bond [3,4].
According to the NMR studies of staphylococcal nuclease
(SNase), the structural heterogeneity can be ascribed to the
isomerizations about the Lys116^Pro117 and His46^Pro47
peptide bonds [5]. The heterogeneity in the native state was
eliminated by the substitution of glycine for Pro117. The iso-
merizations about these two peptide bonds of SNase occur
independently and produce the four di¡erent native conform-
ers [6].
The role of Xaa^Pro peptide bond isomerizations in the
kinetics of protein folding has been investigated thoroughly,
and it is now widely accepted that such isomerizations
are often the reason for slow steps in protein folding reac-
tions [7]. In addition, it has been suggested that this isomer-
ization can play an important role in protein function; for
example, a proline may be actively involved in the regulation
of transmembrane proteins such as the sodium pump, by
having cis/trans isomerization synchronous with ion translo-
cation [8].
The relationship between multiple conformations and pro-
tein function is of great interest nowadays. It has been be-
lieved that the studies on the a¡ection of multiple conforma-
tions of proteins will shed light on the understanding of
protein folding mechanism both in thermodynamic and ki-
netic processes.
Adenylate kinase (AK, EC 2.7.4.3) is a ubiquitous multiple-
domain enzyme that controls the cellular energy balance by
catalyzing the transfer of a phosphoryl group from ATP to
AMP: MgATP+AMPIMgADP+ADP [9]. Close to 20 crys-
tal structures of various AKs have been solved thus far [10].
The enzyme contains two distinct nucleotide binding sites: the
MgATP site, which binds MgATP and MgADP, and the
AMP site, which is speci¢c for AMP and uncomplexed
ADP [11]. The catalytic mechanism and the substrate-induced
conformational changes of AK have been the subject of a
number of investigations [12^16]. We previously observed
that at least two conformational forms of rabbit muscle AK
with di¡erent binding ability to £uorescence probe, 8-anilino-
1-naphthalene sulfonic acid (ANS) exist in equilibrium in so-
lution. The ratio of the two conformers was 70:30%, and the
major form bound rapidly to ANS whilst the minor form had
to convert to the major form before it bound to ANS [13].
Further study on the functional meaning of multiple confor-
mations may improve our understanding of the catalytic
property and folding process for AK.
It was suggested that the conformational changes in AK be
involved in proline isomerization [14,17,18]. In this work, pro-
line 17 of chicken muscle AK has been replaced by glycine or
valine using site-speci¢c mutagenesis to investigate the struc-
ture and functional role of the proline residue. The chicken
muscle cytoplasmic enzyme is a single polypeptide of 194 ami-
no acid residues (MrW22 000 Da), and sequence comparisons
indicate nearly 93% homology with several other muscle-de-
rived cytoplasmic AK species [19]. Proline 17 is located in a
highly conserved glycine-rich, £exible polar loop (Gly15-Gly-
Pro-Gly-Ser-Gly-Lys-Gly22), which is assigned to the part
of the MgATP binding and ANS binding domain [11,20].
The results demonstrated that the mutation at proline 17
altered the distribution of multiple conformers, the substrate
and inhibitor binding ability and the catalysis e⁄ciency of
AK.
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2. Materials and methods
2.1. Chemicals
Adenosine monophosphate (AMP), adenosine diphosphate (ADP),
adenosine triphosphate (ATP), nicotinamide adenine dinucleotide
phosphate (NADP), nicotinamide adenine dinucleotide, reduced
(NADH), phosphoenolpyruvate (PEP), P1,P5-bis(adenosine-5P-)penta-
phosphate (Ap5A), ANS, hexokinase and pyruvate kinase were from
Sigma (St. Louis,MO, USA), lactate dehydrogenase from Roche and
glucose-6-phosphate-dehydrogenase from Boehringer Mannheim (In-
dianapolis, IN, USA).
2.2. Plasmid construction, protein expression and puri¢cation
Plasmid pBV-cak1 for expression of wild-type chicken muscle AK
was constructed as described by Jing et al. [21]. The synthetic primers
5P-TGGGTGGCGGCGGCTCA-3P and 5P-TGGGTGGCGTCGGC-
TCA-3P were used to amplify the mutant P17G and P17V AKs, re-
spectively, in which the mutation positions were underlined in the
oligonucleotide sequence, the CCC (proline) codon was altered to a
GGC (glycine) or a GTC (valine) codon. The expression plasmid
pBV221-cak1 was used as a template and the site-directed mutagenesis
was performed by PCR. DNA fragments carrying the point mutation
were subcloned into the plasmids pBV221 (for P17G mutant) or
pET-3a (for P17V mutant) using the protocol as described previously.
The full-length wild-type AK, P17G and P17V mutant gene sequenc-
ing was performed with an autosequencer (ABI PRISM 377XL DNA
Sequencer, Perkin-Elmer, Norwalk, CT, USA) to ensure that no
undesirable mutations had occurred. Automated Edman degradation
technique was used to determine the amino-terminal protein sequence
of P17G mutant. Overnight culture of Escherichia coli (DH5K) cells
containing the respective plasmid for expression of wild-type and
P17G mutant AK was added at 37‡C to 2 l of Luria broth (LB)
medium plus ampicillin (50 Wg/ml). At OD600 = 0.5, expression was
induced with a temperature upshift to 42‡C, and the cells were grown
at 42‡C for an additional 5 h. P17V mutant was expressed in the
BL21(DE3) strain of E. coli. Protein expression was induced in LB
culture with 0.4 mM isopropyl-L-thiogalactose (IPTG) when the
OD600 of the culture reached 0.8. After an additional 3^4 h of incu-
bation at 37‡C, the cells were collected by centrifugation. The data
indicated that part of wild-type and total P17G and P17V mutant AK
were present in the insoluble fraction, i.e. contained in cell inclusion
bodies. The puri¢ed inclusion bodies were obtained as reported by
Gross et al. [22].
The inclusion bodies were dissolved in 30 ml 6 M urea in 25 mM
Tris^HCl, pH 7.5, 1 mM EDTA, 5 mM L-mercaptoethanol, by stir-
ring overnight at 4‡C. The supernatant of denatured proteins was
subjected to cation exchange chromatography on POROS HS/M col-
umn (Boehringer, Mannheim, Germany), which was equilibrated with
the above-mentioned bu¡er and 6 M urea and eluted with a linear
gradient of NaCl from 0 to 0.5 M at a £ow rate of 2 ml/min. The
pooled fractions were dialyzed against 50 mM Tris^HCl, pH 7.5, 0.15
M NaCl and 5 mM L-mercaptoethanol. The supernatant was pelleted
with 90% saturated (NH4)2SO4 and applied to Sepharcryl S-100 mo-
lecular size exclusion chromatography. The collected fractions were
detected by 12% sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis (SDS^PAGE) and the presence of a single band of AK pro-
tein was con¢rmed.
2.3. The absorbance, CD and £uorescence spectra
The absorbance spectra during the ultra-violet range were recorded
on a Shimazu UV-2501 spectrometer. CD experiments were per-
formed on a Jasco J-720 spectropolarimeter using a thermostatic cu-
vette with 1 mm path length at 25‡C. The baselines due to the bu¡er
(50 mM Tris^HCl, pH 7.5, 5 mM L-mercaptoethanol) were subtracted
from the spectra.
The intrinsic £uorescence spectra and the time course of ANS bind-
ing to AK £uorescence were measured on a Shimazu RF-5301PC
spectro£uorophotometer at 25‡C using a 1 cm thermostatic cuvette.
In the intrinsic £uorescence emission spectra measurements, the ex-
citation wavelength was set at 295 nm and the slit widths were 5 nm.
To record the time course of ANS binding to AK, the excitation and
emission wavelengths were separately set at 378 nm and 478 nm,
respectively, and the slit widths were set to 5 nm.
Protein concentration was 5 WM and ANS concentration was 200
WM. The bu¡er contained 50 mM Tris^HCl, pH 7.5, and 2 mM L-
mercaptoethanol. Bu¡er plus ANS controls containing no protein
were subtracted automatically.
2.4. Enzyme assay and kinetics
The rate of the forward reaction (MgATP+AMPCMgADP+ADP)
was measured by following the oxidation of NADH at 340 nm cou-
pling with pyruvate kinase and lactate dehydrogenase. Measurements
of the velocity of the backward reaction (MgADP+ADPCMgATP
+AMP) were performed by monitoring the reaction of NADP at 340
nm in a coupled enzyme solution with hexokinase and glucose-6-phos-
phate dehydrogenase [14].
To obtain kinetic parameters, enzyme activity was measured as the
concentration of either nucleotide was varied. In the case of wild-type
AK, the apparent Km for MgATP (AMP) was determined as the
concentration of AMP (MgATP) was 2 mM and Mg free was 1.5
mM. The concentrations of MgADP and ADP were 0.2 mM and
0.5 mM, respectively, which were used to determine the apparent
Km for ADP and MgADP. As for the P17G mutant AK, the concen-
trations of the ¢xed nucleotides, i.e. MgATP or AMP, were 5 mM
and Mg free was 1 mM, the varied concentrations were changed in the
region of 0.1^2.0 mM. In the backward reaction, the ¢xed concentra-
tions for MgADP and ADP were 5 mM and 2 mM, respectively.
The inhibition of Ap5A for wild-type and P17G mutant chicken
muscle AK was assayed in the forward and backward reaction by
adding various amounts of MgAc2, ATP, AMP, ADP and Ap5A to
the standard reaction mixture.
All reactions were measured in a Shimazu UV2501 spectrometer at
25‡C. An adequate amount of enzyme that had been diluted with 50
mM Tris^HCl containing 2 mM L-mercaptoethanol and 7.6 WM bo-
vine serum albumin was added to the assay mixture. The ¢nal con-
centrations of wild-type and mutant P17G were 0.5 WM and 4.3 WM in
all kinetic measurements, respectively. One unit of enzyme activity is
de¢ned as the amount which produces 1 Wmol ADP in 1 min.
3. Results
3.1. Site-directed mutagenesis and puri¢cation of expressed
protein
The entire gene sequencing of wild-type, P17G and P17V of
AK showed the correct DNA sequences were obtained. N-
terminal sequencing of the mutants P17G and P17V was per-
formed with PVDF membrane-blotted material by automated
Edman degradation. The N-terminal sequence was assigned to
be Ser-Thr-Glu-Lys-His-His for P17G, which was identical to
that predicted from the cDNA sequence except that the NH2-
terminal methionine was absent and agreed to the previous
report [19]. The mutant proteins migrated as expected for a
protein with a molecular weight of 22 000 Da. The wild-type
enzyme and both mutants were prepared from refolding of
inclusion bodies. The P17G and P17V mutants possessed
the same chromatographic elution patterns as the wild-type
enzyme.
Table 1
Apparent kinetic parameters for wild-type and P17G mutant AK
Protein Km AMP (mM) Km MgATP (mM) Km ADP (mM) Km MgADP (mM) Vmax (units/mg)a
Wild-type 0.17 0.15 0.0035 0.21 1623
P17G mutant 3.4 5.1 0.0098 1.1 650
aThe Vmax value was obtained when the concentration of MgATP was varied.
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3.2. Changes of conformational distribution of P17G probed by
ANS £uorescence
In the previous study of this laboratory, ANS binding £uo-
rescence was found to be a sensitive and e¡ective measure-
ment to detect the multiple conformations of rabbit muscle
AK in solution. The ratio of the relative amplitudes of di¡er-
ent kinetic phases represented the ratio of individual conform-
ers and the rate constant of the slow phase of ANS binding
indicated the converting rate between di¡erent conformers at
some extent [13]. The replacement of proline 17 by glycine of
the chicken muscle AK alters the time course of ANS binding
£uorescence as compared to the wild-type enzyme. The £uo-
rescence changes along with ANS binding displayed two dis-
tinguished kinetic phases: the fast phase completed in the
dead time of manual mixing, and the slow phase reached
the constant value in about 30 min, as shown in Fig. 1. The
£uorescence traces for the slow phase could be ¢tted to a
monoexponential function. The ¢tted rate for P17G mutant
(0.00185 s31) is obvious slower than that for the wild-type
enzyme (0.00451 s31), as well as the relative amplitude of
the slow phase ANS £uorescence of P17G mutant (9%) was
declined to about 1/2 that of the wild-type (18%).
3.3. Conformational changes of AK due to proline 17 to
glycine mutation
The absorbance and intrinsic £uorescence spectra of the
mutant and wild-type AK showed that the P17G mutant
did not deviate signi¢cantly from those of the wild-type. How-
ever, the CD spectra of wild-type and mutant enzyme indi-
cated the considerable loss of secondary structure content due
to the replacement of proline 17 by glycine. As can be seen
from Fig. 2, the secondary structure content of P17G mutant
was decreased to about 75% of that of wild-type AK.
3.4. Comparison of kinetic parameters for wild-type and
mutant P17G AK
A complete summary of kinetic parameters that were calcu-
lated using the previous reported method [14] was given in
Table 1. The mutation of proline 17 to glycine of the chicken
muscle AK resulted in a 2.5-fold reduction in the observed
maximal velocity (in the forward reaction) as compared to the
wild-type enzyme. The apparent Km values of the P17G mu-
tant for AMP and MgATP were increased approximately by
20- and 34-fold, respectively. The results suggest that the mu-
tation at residue proline 17 in£uenced both the binding of
substrates and the catalytic e⁄ciency of the enzyme, which
had a slight di¡erence with a previous report by Tagaya et
al. [23]. Furthermore, proline 17 played a more important role
for the binding of substrates MgATP and AMP in the for-
ward reaction.
3.5. Ap5A inhibition e¡ect on the wild-type and
mutant P17G AK
Ap5A is a bisubstrate analogue of AK. It was reported by
Kuby et al. that Ap5A acted as a competitive inhibitor for the
forward reaction and a non-competitive inhibitor for the
backward reaction [24]. However, the re-examined data
showed that Ap5A acted as a mixed non-competitive inhibitor
for the backward reaction, which agreed with origin ¢gures
shown in the paper of Kuby et al. [14,24]. In the present
Fig. 1. Time course of £uorescence change with ANS binding to
wild-type and P17G mutant chicken muscle AK. Straight line: wild-
type AK; dashed line: P17G mutant AK. The excitation and emis-
sion wavelengths were separately set at 378 nm and 478 nm, respec-
tively, and the slit widths were set to 5 nm. Protein concentration
was 5 WM and ANS concentration was 200 WM. The bu¡er contains
50 mM Tris^HCl, pH 7.5, and 2 mM L-mercaptoethanol.
Fig. 2. CD spectra of wild-type, P17G mutant chicken muscle AK.
All proteins were measured at a protein concentration of 5 WM in
50 mM Tris^HCl, pH 7.5, 5 mM L-mercaptoethanol, at 25‡C using
an optical path of 0.1 cm.
Table 2
Inhibition constants of Ap5A with wild-type and P17G mutant AK
Protein Ki AMP (M) Ki MgATP (M) Ki ADP (M) Ki MgADP (M)
Wild-type 2.05U1037 2.32U1037 1.26U1038 1.15U1037
P17G mutant 1.10U1035 8.53U1036 3.66U1036 2.70U1036
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study, similarly the inhibition pattern of Ap5A for the chicken
muscle AK was di¡erent between various substrates. The re-
sults were shown in Fig. 3, which demonstrated clearly that
the inhibition was competitive with respect to the forward
reaction substrates: MgATP and AMP; and was mixed
non-competitive with respect to the backward reaction sub-
strates: MgADP and ADP. For both the wild-type and P17G
mutant AK, the Ap5A inhibition patterns seemed alike except
with di¡erent e¡ective inhibitor concentration regions.
The parameters Ki were obtained according to the previous
study [24] and listed in Table 2. The increased concentrations
of Ap5A necessary to inhibit the P17G enzyme indicated a
signi¢cantly reduced a⁄nity for the bisubstrate analogue.
3.6. Study on the mutant of P17V AK
In the above experiment, a highly conformationally re-
stricted proline is mutated to a glycine in a loop region, which
is already rich in glycine. It may well be that the entropic
e¡ect of incorporating yet another £exible residue into the
loop is su⁄cient to destabilize the protein and cause the ef-
fects observed, i.e. loss of structural content, reduced ligand
a⁄nity, and lower catalytic e⁄ciency [25]. To test this issue,
an alternative mutant of P17V (replace proline 17 by valine)
was constructed and studied. The mutant P17V shows the
similar e¡ect on the conformational and functional changes
as mutant P17G. The speci¢c activity and secondary structure
content of P17V are decreased to about 10% and 60% of that
of the wild-type, respectively. The time course of ANS binding
to P17V displayed also a burst phase and a slow phase with a
ratio of amplitude of burst phase to slow phase 89:11. This
result excludes the possibility that the observed conformation-
al and functional changes of P17G are caused by the unique
e¡ect of glycine as a £exible residue and potent cis conforma-
tion contributor. The attempt to obtain the kinetics and Ap5A
inhibition parameters of P17V failed, since the speci¢c activity
of P17V is too low.
4. Discussion
The e¡ects of proline mutations on the structure and func-
tion of the protein are remarkably di¡erent among the indi-
vidual proteins or di¡erent among the mutation sites in the
same protein depending on structural context. The local per-
turbation resulting from the removal of proline residues sig-
ni¢cantly altered the stability and folding kinetics in some
proteins [6]. SNase is known to exhibit proline isomerization
in not only the unfolded but also the native state, and this
gives rise to structural heterogeneity in the native state. The
P117G mutation increased the protein stability and a¡ected
both refolding and unfolding kinetics [6]. On the other hand,
in some cases, no gross structural changes occurred upon pro-
line substitution even in those proteins that had the multiple
conformations arising from proline isomerization [4]. For cal-
bindin D9K, structural perturbations due to proline isomer-
ization were localized and the globular conformations of the
two forms were very similar [4].
In the case of AK from chicken muscle, proline 17 is lo-
cated in a highly conserved glycine-rich, £exible polar loop
(Gly15-Gly-Pro-Gly-Ser-Gly-Lys-Gly22), which together with
the more distal residues Lys27, Phe183 and Leu190 appears
to de¢ne components of the MgATP binding domain [20].
Furthermore, this loop remarkably moves during the transi-
tion between two crystal forms [11,12]. The results in this
report showed that the substitution of proline 17 in AK re-
markably a¡ected the secondary structure content, the multi-
ple conformational distributions, enzyme catalytic activity and
the a⁄nity to the inhibitor Ap5A.
As has been determined by site-speci¢c mutagenesis experi-
ments, when proline 17 is mutated to glycine or valine, the
fraction of fast and slow phase of ANS binding £uorescence is
changed signi¢cantly. Meanwhile, catalytic activity decreased
2.5-fold for P17G and 10-fold for P17V, and the a⁄nity of the
enzyme for both substrates as well as the bisubstrate analogue
Ap5A is decreased substantially (see Tables 1 and 2). The
present results suggest that the replacement of proline 17 by
glycine or valine causes conformational alterations, and even
subtle alterations in the local environment may signi¢cantly
in£uence the distribution of multiple conformers, conse-
quently in£uence the function of the enzyme. The proline 17
residue is essential for retaining the proper conformation and
positioning the substrate binding residues to achieve high sub-
strate a⁄nity and high activity.
As a summary, proline 17 plays an essential role on keeping
Fig. 3. Inhibition pattern of Ap5A for P17G chicken muscle AK.
A: In the forward reaction. B: In the backward reaction.
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the multiple conformations of AK. The full expression of
catalytic activity of AK relies on the proper conformation
distribution and discrete substrate binding conformation.
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